Recent appointment of Kyle Diamantas as acting FDA commissioner following Marty Makary’s resignation has elevated his standing as the frontrunner for a formal White House announcement. President Trump publicly described Diamantas, who previously led the agency’s food oversight division, as a “very talented person,” underscoring administration preference for an internal candidate with operational experience. Traders assign this outcome the highest probability, reflecting the immediate transition and limited public signals favoring external alternatives such as Stephen Hahn or Brett Giroir. An ongoing search for a permanent nominee continues under HHS oversight, yet the absence of competing announcements or major policy shifts keeps the current acting leader ahead in market positioning through year-end.